Is hyperviscosity a treatable component of diabetic microcirculatory disease? - Test2 - elhamkhani - TriplyDB

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

http://www.wikidata.org/entity/Q39455422

about

Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus Specific calcium antagonists in the treatment of peripheral vascular disease Erythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathy Biomechanical properties of red blood cells in health and disease towards microfluidics.Influence of D- and L-glucose on erythrocytes and blood viscosity.Blood and plasma viscosity measurements in patients with glaucoma.Hypoxic viscosity and diabetic retinopathy.Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy.Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease.Antioxidant Vitamins and Lipoperoxidation in Non-pregnant, Pregnant, and Gestational Diabetic Women: Erythrocytes Osmotic Fragility Profiles.Capillary dysfunction: its detection and causative role in dementias and stroke Anemia and diabetes.The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus.Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities.Correlations between fatty acid composition of the erythrocyte membrane and blood rheology data.Lower Hemoglobin Concentration Is Associated with Retinal Ischemia and the Severity of Diabetic Retinopathy in Type 2 Diabetes.Stroke topography and outcome in relation to hyperglycaemia and diabetes Role of C-Peptide in the regulation of microvascular blood flow.Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities.Association between diabetic retinopathy and hemoglobin level.Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy Hemorheological disorders in diabetes mellitus Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.Molecular effects of C-Peptide in microvascular blood flow regulation.Blood rheology.Haemorheological aspects of thrombosis.Abnormal microvasculature in diabetic neuropathy.Management of the diabetic foot Effects of ketanserin, a 5-HT2-receptor antagonist, on the blood flow response to temperature changes in the diabetic foot.Regional cerebral glucose utilization during hyperglycemia.Blood rheology in vegetarians.Blood viscosity and erythrocyte deformability in gestational diabetes.Specific heart disease in diabetes mellitus.Cinnarizine in the treatment of peripheral vascular disease: mechanisms related to its clinical action.Cerebrovascular responsiveness to NG-nitro-L-arginine methyl ester in spontaneously diabetic rats.The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.Reduced number of circulating monocytes after institution of insulin therapy--relevance for development of atherosclerosis in diabetics?50th Bowman lecture. 'Blood is thicker than water'. Some haemorheological aspects of ocular disease.

P2860

Q26776375-FC96A4FC-F2F4-4801-8706-8BAC261CE8B9 Q27016081-0419BE1B-A74E-4665-8748-7CF7AA2C9813 Q28244018-2F26DD69-B629-4D90-90A5-D9C95CDBF1C4 Q28542790-31D82A1F-9D23-44B1-86E7-D655EE71D00B Q30402763-3DC5C442-4DD6-4B0B-9554-2CE192053144 Q31898221-9D76C98E-FCBE-49FC-A368-457B568796C3 Q33644489-1BAF130C-D7B9-4CF7-9991-6B0D424F5937 Q33648124-BFA72A5B-662F-4203-8B63-A2D94D9FA9D4 Q34708941-CAD3DD6F-52EF-41C3-8A91-F15A2A387243 Q35153023-FD00A969-C099-4635-A658-64C8055B4DC9 Q35284785-A612BEC5-8EF7-4F95-B5AB-9D298DD3075D Q35356099-559E2607-7CE5-4357-8ABC-D3D5AFDC0F27 Q35639179-0C61BA27-18BE-4DDE-AE97-BFD290152B12 Q35903486-BE48EA9B-F203-498F-824B-FC5A6E155434 Q36028712-E451FF1D-8F5D-46F6-9882-8BBF2A6B3D65 Q36778735-4877D263-ABF2-4EAF-9927-5A7206C9E5B8 Q36811689-53A529FB-AA94-474B-A3B5-9B0457992CA8 Q36864167-ECA2A421-A304-44C5-A995-EE169906B24F Q36960378-B50FEB2C-6BF0-4D88-9254-2C780A37A909 Q37231760-AE916D12-4584-4658-8FD8-0A9B602F253F Q37309890-D278DC1A-D22E-48C9-BA96-48CB2F8F3DE3 Q37345959-E442ED7C-4FD9-415D-82C2-754567446E88 Q37576420-B55BAA3C-518B-469C-A048-6C3C8A4BAE0C Q37626485-98DA1541-5825-42E1-8254-197EE3BB79E9 Q38903618-8C91C011-268A-4556-98EB-79FE0E62937B Q39224550-08F948B2-FA53-4771-B7AF-F8375EF9A335 Q40288209-3FCD00F7-F57C-439A-B412-6B2DAA94BCE3 Q40292606-77E61DBB-01AD-4E63-9FA0-E9390A8F040F Q40442541-FACE056A-A9B5-4139-9092-140EE663A4DC Q41260700-ADFAB47E-397A-4757-9D02-8BF349606B57 Q41352515-1671CB5C-F697-436E-923A-E6C01508A0A6 Q41354768-63330C23-D6D2-4983-8666-06C13613E3C8 Q41465435-3352B413-0477-4445-9AD6-6EB15E8444FA Q41536712-D6C8DDC7-E26E-41D7-88A5-A8719D9E6849 Q42345954-E81019BB-67FD-47AD-A289-C5E37B2AAC67 Q42700593-C7DCDE77-058A-46F2-9B6F-3ED9B59B5F7B Q42704302-77E46413-8EF4-485F-8FB5-1239E1AE6323 Q42920667-211E87A6-9EEF-4AC2-9F8B-1366E1794635 Q47957682-A7B853C5-B48D-4827-8319-C57BE101D2B3 Q48531348-7E1253F0-0E89-44A4-A72F-306586B79CED

P2860

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

http://www.wikidata.org/entity/Q39455422

description

1977 nî lūn-bûn

@nan

1977年の論文

@ja

1977年学术文章

@wuu

1977年学术文章

@zh-cn

1977年学术文章

@zh-hans

1977年学术文章

@zh-my

1977年学术文章

@zh-sg

1977年學術文章

@yue

1977年學術文章

@zh

1977年學術文章

@zh-hant

name

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@en

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@nl

type

label

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@en

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@nl

prefLabel

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@en

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@nl

P1433

Q39455422-09A380FE-E1FF-4FB5-93D4-0C44AD8659A5

P1476

Q39455422-A9DDBB5C-1C50-412D-9F81-AE3C1EE8183F

P2093

Q39455422-07A442D0-19D2-4F0C-9694-906D976C6F62

Q39455422-2077FF28-0B22-44BF-9C24-C60FF79FADC9

Q39455422-35BE88A0-F407-441E-B82A-EE0FC2FBACFE

Q39455422-620C74F6-1B81-4BE6-B40B-6777B29B45E8

Q39455422-A35F3E8A-F0AF-43D7-BD75-5A9A8F4B29A4

Q39455422-D249DA52-B9A7-4904-891F-5099778CCA6D

P304

Q39455422-5D59B6C6-7DB2-4788-B52B-8118FBB22C96

P31

Q39455422-F195C0A8-8BE7-4C6B-9F24-FCF4434AD473

P356

Q39455422-8020579A-55AB-4E71-99F0-75BEA7A08DC6

P407

Q39455422-533B6DFF-3909-4661-B176-E5D8FD804BFB

P433

Q39455422-2FFBF0AA-00C8-401C-B38B-76CE4DEC0267

P478

Q39455422-74AE9C43-A937-4458-AF77-06D86F3B381B

P577

Q39455422-4702A70C-0072-4C79-8DD5-F724FB44006C

P698

Q39455422-952BCD13-FFB6-49C5-9EF4-642BE7CA7448

P356

S0140-6736(77)90724-3

P1433

P1476

Is hyperviscosity a treatable component of diabetic microcirculatory disease?

@en

P2093

A J Barnes

http://www.w3.org/2001/XMLSchema#string

J A Dormandy

http://www.w3.org/2001/XMLSchema#string

J Slack

http://www.w3.org/2001/XMLSchema#string

P Locke

http://www.w3.org/2001/XMLSchema#string

P R Scudder

http://www.w3.org/2001/XMLSchema#string

T L Dormandy

http://www.w3.org/2001/XMLSchema#string

P304

789-791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(77)90724-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

8042

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

1977-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

71601

http://www.w3.org/2001/XMLSchema#string